Chronic Hepatitis Delta Infection clinical trials

Explore recruiting chronic hepatitis delta infection clinical trials.

Recruiting chronic hepatitis delta infection studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic Hepatitis Delta Infection trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomized, Open-label, Multicenter, Phase 3 Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-4)

Belgium, Hungary, Bulgaria

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Global, Randomized, Open-label, Multicenter, Phase 2b/3 Trial Evaluating BJT-778 vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-1)

Bulgaria

Phase II and Phase III (Integrated) EU CTIS Study details

A Global, Randomized, Open-label, Multicenter Phase 3 Trial Evaluating BJT-778 vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)

Austria, Italy, Czechia, Romania, Sweden, Spain +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2b/3, Open-Label, Multicenter Trial Evaluating the Efficacy and Safety of Switching to Brelovitug for the Treatment of Chronic Hepatitis Delta Infection in Participants Receiving Bulevirtide (AZURE-3)

Czechia, Austria, Spain, Romania, Germany, Italy +1 more

Phase II and Phase III (Integrated) EU CTIS Study details

Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta.

Italy, Romania, Germany, Bulgaria

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Chronic Hepatitis Delta Infection trials by city

Chronic Hepatitis Delta Infection in Toronto Chronic Hepatitis Delta Infection in Vancouver Chronic Hepatitis Delta Infection in Montreal Chronic Hepatitis Delta Infection in Calgary Chronic Hepatitis Delta Infection in Edmonton Chronic Hepatitis Delta Infection in Ottawa Chronic Hepatitis Delta Infection in Winnipeg Chronic Hepatitis Delta Infection in Quebec City Chronic Hepatitis Delta Infection in Hamilton Chronic Hepatitis Delta Infection in Kitchener Chronic Hepatitis Delta Infection in London Chronic Hepatitis Delta Infection in Halifax Chronic Hepatitis Delta Infection in New York Chronic Hepatitis Delta Infection in Los Angeles Chronic Hepatitis Delta Infection in Chicago Chronic Hepatitis Delta Infection in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease